MEDIROM Healthcare Technologies Inc. (MRM) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    MEDIROM Healthcare Techno...

    NASDAQ: MRM · Real-Time Price · USD
    1.80
    -0.11 (-5.76%)
    At close: Aug 29, 2025, 3:57 PM
    1.85
    2.78%
    After-hours: Aug 29, 2025, 07:58 PM EDT

    MEDIROM Healthcare Income Statement

    Financials in JPY. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Revenue
    		 8.3B 7.06B 6.83B 7.05B 5.38B 3.21B 2.7B 2.06B
    Cost of Revenue
    		 6.05B 5.59B 5.26B 5.28B 3.89B 2.28B 2B 1.71B
    Gross Profit
    		 2.25B 1.47B 1.57B 1.77B 1.49B 936.32M 707.71M 350.23M
    Operating Income
    		 -18.1M -717.99M -391.58M -58.41M 174.99M -33.45M -197.69M -343.73M
    Interest Income
    		 8K 18.9M 35.76M 16.86M 2.67M 5.14M 5.55M 6.34M
    Pretax Income
    		 47.71M -212.82M 20.62M -12.7M 259.2M -53.39M -207.24M -334.65M
    Net Income
    		 148.76M -111.71M 115.4M -24.56M 239.74M -325.25M -495.37M -308.98M
    Selling & General & Admin
    		 2.24B 2.18B 1.96B 1.83B 1.32B 969.76M 905.39M 693.97M
    Research & Development
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Other Expenses
    		 22.87M n/a n/a -1.17M -1.17M n/a n/a n/a
    Operating Expenses
    		 2.26B 2.18B 1.98B 1.85B 1.32B 984.57M 909.39M 678.54M
    Interest Expense
    		 49.74M n/a n/a n/a n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a 162.03M 162.03M 135.13M 135.13M 65.48M 65.48M 46.23M
    Cost & Expenses
    		 8.32B 7.78B 7.24B 7.13B 5.21B 3.26B 2.91B 2.38B
    Income Tax Expense
    		 -90.48M 101.77M 101.9M 11.86M 19.47M 271.86M 288.12M 80.88M
    Shares Outstanding (Basic)
    		 5.11M 4.91M 5.45M 4.88M 6.06M 4.88M 4.88M 4.87M
    Shares Outstanding (Diluted)
    		 5.85M 4.91M 5.45M 4.88M 6.06M 4.88M 4.88M 4.87M
    EPS (Basic)
    		 0.19 -32.24 13.60 -18.18 35.95 -66.61 -101.57 -65.49
    EPS (Diluted)
    		 0.17 -32.24 13.60 -18.18 35.95 -66.62 -101.58 -65.5
    EBITDA
    		 387.5M -370.14M -138.98M 134.9M 312.67M 55.07M -134.57M -309.33M
    EBIT
    		 97.46M -717.99M -391.58M -59.59M 173.82M -33.45M -197.69M -343.73M
    Depreciation & Amortization
    		 290.04M 347.85M 252.59M 194.49M 138.85M 88.52M 63.12M 34.41M

    Add to Watchlist